ABOVE: Former BARDA Director Rick Bright (center) with National Institute of Allergy and Infectious Diseases Director Anthony Fauci (left) and Marilyn Serafini, former president and co-CEO of the Alliance for Health Reform
WIKIMEDIA, ALLIANCE FOR HEALTH POLICY
Update (August 9, 2021): Rick Bright will be compensated for “emotional stress and reputational damage” following the settlement of his whistleblower complaint against the federal government, though the details of the agreement remain undisclosed, The New York Times reports. Bright claims that the administration of former President Donald Trump put “politics and cronyism ahead of science” and removed him from his position overseeing COVID-19 vaccine development efforts because he pushed for more research into the anti-malaria drug hydroxychloroquine before issuing an emergency use authorization for its use for COVID-19. The Times reports that the Office of Special Counsel is still investigating those allegations.
Update (May 8): Rick Bright’s lawyers announced that the federal agency ...
